本页面由Tiger Trade Technology Pte. Ltd.提供服务

Salarius Pharmaceuticals Inc

0.8400
0.0000
成交量:- -
成交额:468.84万
市值:536.27万
市盈率:-0.02
高:0.8400
开:0.8400
低:0.8400
收:0.8400
52周最高:108.00
52周最低:0.5148
股本:638.42万
流通股本:634.18万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-39.1909
每股收益(LYR):-86.9214
净资产收益率:-139.55%
总资产收益率:-69.91%
市净率:1.26
市盈率(LYR):-0.01

数据加载中...

2020/02/12

重要事件披露

Current report, items 3.03, 5.03, 7.01, 8.01, and 9.01
2020/02/06

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/01/29

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/28

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2020/01/10

招股说明书

General form for registration of securities under the Securities Act of 1933
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/28

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2019/10/22

重要事件披露

Current report, item 5.07
2019/09/18

重要事件披露

[Amend] Current report, items 8.01 and 9.01
2019/09/16

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2019/08/12

重要事件披露

Current report, items 7.01 and 9.01
2019/07/29

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/29

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/29

超过5%披露

General statement of acquisition of beneficial ownership
2019/07/24

重要事件披露

Current report, items 1.01, 2.01, 4.01, 7.01, and 9.01
2019/07/23

持股变动声明

Initial statement of beneficial ownership of securities
2019/07/23

持股变动声明

Initial statement of beneficial ownership of securities
2019/07/23

持股变动声明

Initial statement of beneficial ownership of securities